Hormonal Therapy News and Research

RSS
Hormonal Therapy is treatment that adds, blocks, or removes hormones. For certain conditions (such as diabetes or menopause), hormones are given to adjust low hormone levels. To slow or stop the growth of certain cancers (such as prostate and breast cancer), synthetic hormones or other drugs may be given to block the body’s natural hormones. Sometimes surgery is needed to remove the gland that makes a certain hormone. Also called endocrine therapy, hormone therapy, and hormone treatment.
Drug combination therapy delays progression of advanced breast cancer without side effects, study shows

Drug combination therapy delays progression of advanced breast cancer without side effects, study shows

Study shows menopausal hormone therapy can improve bone mass and structure

Study shows menopausal hormone therapy can improve bone mass and structure

Identifying gene defects may help develop individualised treatments for prostate cancer patients

Identifying gene defects may help develop individualised treatments for prostate cancer patients

Painful sex in women after cancer needs to be addressed, UC Davis researcher suggests

Painful sex in women after cancer needs to be addressed, UC Davis researcher suggests

Study examines benefits of hormonal therapy for prostate cancer patients with prior history of heart attack

Study examines benefits of hormonal therapy for prostate cancer patients with prior history of heart attack

ATS releases new clinical practice guidelines for diagnosis, management of LAM

ATS releases new clinical practice guidelines for diagnosis, management of LAM

PSA failure linked to increased risk of death among healthy men

PSA failure linked to increased risk of death among healthy men

New research discovers how opposite-sex hormonal therapy influences the brain

New research discovers how opposite-sex hormonal therapy influences the brain

Researchers to develop new test to predict therapy for women with ER+ breast cancer

Researchers to develop new test to predict therapy for women with ER+ breast cancer

Intrinsic subtyping of breast cancer can aid prognosis, treatment of tumor patients

Intrinsic subtyping of breast cancer can aid prognosis, treatment of tumor patients

New research reveals advances that could change gynecologic cancer standard-of-care treatments

New research reveals advances that could change gynecologic cancer standard-of-care treatments

Mastectomy followed by standard therapy improves survival in stage IV breast cancer patients

Mastectomy followed by standard therapy improves survival in stage IV breast cancer patients

Researchers spot molecular key that breast cancer cells use to invade bone marrow

Researchers spot molecular key that breast cancer cells use to invade bone marrow

Multi-gene test can help identify early breast cancer patients who can safely be spared chemotherapy

Multi-gene test can help identify early breast cancer patients who can safely be spared chemotherapy

Delivering microRNAs in cancer treatment: an interview with Dr Conde and Prof Artzi

Delivering microRNAs in cancer treatment: an interview with Dr Conde and Prof Artzi

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

Active surveillance may be a viable treatment for select DCIS patients

Active surveillance may be a viable treatment for select DCIS patients

Combination treatment provides effective one-two punch against prostate cancer

Combination treatment provides effective one-two punch against prostate cancer

Uninsured, low-income breast cancer patients less likely to continue hormonal therapy

Uninsured, low-income breast cancer patients less likely to continue hormonal therapy